Recilisib
Recilisib (ON 01210) is a small molecule radioprotectant that functions by activating the PI3K/AKT signaling pathway. It has demonstrated protective effects in cellular (in vitro) and animal (in vivo) models against radiation-induced damage, supporting its research in radiation biology and oncology.
Product Specifications
CAS Number
334969-03-8
Product Name Alternative
Recilisib, PI3K, PKB, Protein kinase B, Phosphoinositide 3-kinase, ON01210, ON-01210, ON 01210, inhibit, Inhibitor, Ex-RAD, Akt
Field of Research
Signal Transduction
Purity
98.85% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:2.5 mg/mL (7.42 mM) ; DMSO:50 mg/mL (148.46 mM)
Smiles
OC (=O) c1ccc (\C=C\S (=O) (=O) Cc2ccc (Cl) cc2) cc1
Molecular Formula
C16H13ClO4S
Molecular Weight
336.79
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-62939R-Cy7-01 20 µL
Phospho-POLR2A (Ser2) Recombinant Antibody, Cy7 Conjugated
Sign In for Pricing
View Details bsm-62939R-Cy7-02 100 µL
Phospho-POLR2A (Ser2) Recombinant Antibody, Cy7 Conjugated
Sign In for Pricing
View Details 
MBS1307156-01 0.02 mg (E-Coli)
Recombinant Rhodopseudomonas palustris Cysteine--tRNA ligase (cysS)
Sign In for Pricing
View Details MBS1307156-02 0.02 mg (Yeast)
Recombinant Rhodopseudomonas palustris Cysteine--tRNA ligase (cysS)
Sign In for Pricing
View Details